HealthPrize partners with pharma and payers to enable people with chronic conditions to take control of their treatment plan and improve their health outcomes
We are happy to start off 2024 with a bang! Read about our recently published paper demonstrating a 44% lift in #medicationadherence in #COPD in collaboration with @boehringerus
and @IQVIA_US https://t.co/0dl27Z0XHU
"Medication adherence according to prescription halves the risk for hospitalized exacerbations...there is vast potential to improve patient-relevant outcomes without 'inventing' a new treatment but by supporting COPD patients" https://t.co/qSwL2pCSYU
Patient: I don’t like the idea of going on a medication for the rest of my life.
Me: I don’t like the idea of you having that uncontrolled risk factor for the rest of your life.
We invite you to read the "expert opinion" section of our recently published paper on our #MedicationAdherence program for #COPD https://t.co/YcoSSwPNKN
Happy #HealthLiteracyMonth! We understand that health literacy is key to sticking with healthy behaviors. Our program's patient education is particularly effective because it is carefully designed with maximal engagement in mind. Check us out! #medicationadherence#healthliteracy
Claims that HealthPrize programs lift #adherence to prescribed medication has been affirmed by the Validation Institution. Results showed a shift from 100% nonadherence to only 17% nonadherence after one year: https://t.co/85jVUYpuIe
Since there’s no standard adherence rate for drugs, it’s important for marketers to do the research to figure out what their drug’s target adherence rate should be. https://t.co/Gt4b6g7M7b
Want to digitally innovate in a highly regulated industry like #Pharma? Scale down before scaling up.
Thanks @PharmExec for sharing our perspective on pilot pathways for digital success https://t.co/QzIiUpgz5Y #DigitalHealth#PatientEngagement
It is estimated that 80 million people in the U.S. are at risk for low health literacy. This number alone signals a problem detrimental to both individuals and healthcare on the whole. #HealthLiteracy https://t.co/rFqOKxEmmR
A case study from @HealthPrize reports that patients on its program for a COPD therapy were more adherent than a control group. Read the details in this week's #KlickWire: https://t.co/bOK3F1qSJJ
.@Boehringer digital rewards club boosts #COPD#medicationadherence by 44%: study - promise of free credits to a favorite retailer is enough to help them stick to a medication regimen. @HealthPrize https://t.co/fE2EXypKxi
HealthPrize's new personalized features provide greater variety to improve patient experience and support behavior change for better outcomes. https://t.co/hXfecGN0ZV #patientexperience